SKAN Group Past Earnings Performance
Past criteria checks 4/6
SKAN Group has been growing earnings at an average annual rate of 22.4%, while the Life Sciences industry saw earnings growing at 16.5% annually. Revenues have been growing at an average rate of 40.4% per year. SKAN Group's return on equity is 15.8%, and it has net margins of 8.2%.
Key information
22.4%
Earnings growth rate
-1.2%
EPS growth rate
| Life Sciences Industry Growth | 17.6% |
| Revenue growth rate | 40.4% |
| Return on equity | 15.8% |
| Net Margin | 8.2% |
| Next Earnings Update | 20 Aug 2024 |
Recent past performance updates
Recent updates
We Take A Look At Why SKAN Group AG's (VTX:SKAN) CEO Has Earned Their Pay Packet
May 01
Is There An Opportunity With SKAN Group AG's (VTX:SKAN) 27% Undervaluation?
Apr 19We Think That There Are Issues Underlying SKAN Group's (VTX:SKAN) Earnings
Apr 03SKAN Group AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 29When Should You Buy SKAN Group AG (VTX:SKAN)?
Mar 11SKAN Group AG's (VTX:SKAN) Earnings Haven't Escaped The Attention Of Investors
Jan 26Estimating The Fair Value Of SKAN Group AG (VTX:SKAN)
Dec 21Is There Now An Opportunity In SKAN Group AG (VTX:SKAN)?
Nov 22A Look At The Fair Value Of SKAN Group AG (VTX:SKAN)
Sep 21How Much Of BV Holding AG (BRN:BVHN) Do Insiders Own?
Mar 11Here's Why I Think BV Holding (BRN:BVHN) Is An Interesting Stock
Feb 04
Did You Participate In Any Of BV Holding's (BRN:BVHN) Fantastic 204% Return ?
Dec 31How Much Of BV Holding AG (BRN:BVHN) Do Insiders Own?
Dec 03Revenue & Expenses BreakdownBeta
How SKAN Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 320 | 26 | 159 | 0 |
| 30 Sep 23 | 308 | 27 | 152 | 0 |
| 30 Jun 23 | 296 | 27 | 145 | 0 |
| 31 Mar 23 | 286 | 23 | 140 | 0 |
| 31 Dec 22 | 277 | 19 | 135 | 0 |
| 30 Sep 22 | 265 | 13 | 129 | 0 |
| 30 Jun 22 | 253 | 7 | 124 | 0 |
| 31 Mar 22 | 244 | 9 | 119 | 0 |
| 31 Dec 21 | 234 | 11 | 115 | 0 |
| 30 Sep 21 | 217 | 7 | 110 | 0 |
| 30 Jun 21 | 200 | 3 | 105 | 0 |
| 31 Mar 21 | 196 | 4 | 101 | 0 |
| 31 Dec 20 | 192 | 5 | 97 | 0 |
| 30 Sep 20 | 150 | 12 | 71 | 0 |
| 30 Jun 20 | 109 | 20 | 45 | 0 |
| 31 Mar 20 | 64 | 19 | 23 | 0 |
| 31 Dec 19 | 19 | 18 | 1 | 0 |
| 30 Sep 19 | 13 | 12 | 1 | 0 |
| 30 Jun 19 | 7 | 6 | 1 | 0 |
| 31 Mar 19 | 7 | 6 | 1 | 0 |
| 31 Dec 18 | 7 | 6 | 1 | 0 |
| 30 Sep 18 | 11 | 8 | 1 | 0 |
| 30 Jun 18 | 14 | 9 | 1 | 0 |
| 31 Mar 18 | 17 | 12 | 1 | 0 |
| 31 Dec 17 | 20 | 15 | 1 | 0 |
| 30 Sep 17 | 17 | 13 | 1 | 0 |
| 30 Jun 17 | 15 | 10 | 1 | 0 |
| 31 Mar 17 | 19 | 13 | 1 | 0 |
| 31 Dec 16 | 24 | 16 | 1 | 0 |
| 30 Sep 16 | 23 | 15 | 1 | 0 |
| 30 Jun 16 | 21 | 14 | 1 | 0 |
| 31 Mar 16 | 22 | 16 | 1 | 0 |
| 31 Dec 15 | 23 | 18 | 1 | 0 |
| 30 Sep 15 | 22 | 19 | 1 | 0 |
| 30 Jun 15 | 21 | 19 | 2 | 0 |
| 31 Mar 15 | 13 | 12 | 1 | 0 |
| 31 Dec 14 | 6 | 4 | 1 | 0 |
| 30 Sep 14 | 6 | 5 | 1 | 0 |
| 30 Jun 14 | 6 | 5 | 1 | 0 |
| 31 Mar 14 | 4 | 4 | 1 | 0 |
| 31 Dec 13 | 3 | 2 | 1 | 0 |
| 30 Sep 13 | 4 | 3 | 1 | 0 |
| 30 Jun 13 | 4 | 3 | 1 | 0 |
Quality Earnings: SKAN has a high level of non-cash earnings.
Growing Profit Margin: SKAN's current net profit margins (8.2%) are higher than last year (6.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SKAN's earnings have grown significantly by 22.4% per year over the past 5 years.
Accelerating Growth: SKAN's earnings growth over the past year (38.6%) exceeds its 5-year average (22.4% per year).
Earnings vs Industry: SKAN earnings growth over the past year (38.6%) exceeded the Life Sciences industry 6.5%.
Return on Equity
High ROE: SKAN's Return on Equity (15.8%) is considered low.